| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |